Stories

She was first told to smoke, then judged for needing a way out. That contradiction captures a long public health failure: people were encouraged into cigarettes by culture, marketing and social norms, then later treated as the problem when they struggled to quit. Harm reduction starts from a more humane place. It recognises dependence, history and circumstance, and gives people safer routes away from combustion without turning their past into a moral verdict.

Retail visibility is not just advertising; it is how many adult smokers discover that alternatives to cigarettes exist. A display ban may make vaping less visible, but it could also make the lower-risk option harder to notice while combustible tobacco remains familiar through habit, history and availability. The policy question should be practical: does hiding legal vapes help people stop smoking, or does it simply make harm reduction less obvious? Public health gains little from making safer choices harder to see.

A call to ban nicotine pouches treats absence as a solution. In practice, it can remove a smoke-free option from adults who want nicotine without returning to cigarettes, while pushing demand into less accountable channels. The more serious question is not whether pouches should exist, but how they should be regulated: age limits, product standards, clear labelling and honest information about relative risk. Public health should control the market, not pretend it can make consumer demand disappear.

Better regulation begins with a simple discipline: look at the evidence before deciding what the policy should say. In tobacco and nicotine control, that means distinguishing between products, measuring actual exposure, and asking whether rules help smokers move away from combustion. Regulation that ignores evidence may still look decisive, but it can harden the wrong incentives and leave the greatest harms untouched. The challenge is not more regulation for its own sake — it is regulation that is proportionate, responsive and honest about risk.

Eight EU health ministers, led by the Netherlands, have urged banning nicotine products outside the Tobacco Products Directive and imposing nicotine caps, flavour bans, plain packaging and standardised devices on remaining products. Critics argue these measures would undermine smoking alternatives and use political pressure to advance restrictions absent from a recent consultation. Nicotine pouches are particularly contentious, with Sweden expected to oppose an EU-wide ban because of their popularity there. The text also warns of political consequences in France and Spain, where upcoming elections could shift government positions. Right-wing parties, including France’s National Rally and Spain’s Vox, have opposed restrictive approaches to vaping or other smoking alternatives.

Canada’s nicotine policy has created a strange kind of protectionism: not for innovation, but for cigarettes. Smoke-free alternatives face restrictions, limited access and public confusion, while the product responsible for the greatest harm remains familiar and widely available. That imbalance matters because smokers respond to what is easiest, cheapest and most clearly explained. A policy that makes safer nicotine harder to reach is not neutral — it leaves cigarettes in the strongest position.

Jack Rankin, Kemi Badenoch’s Parliamentary Private Secretary, suggested the Conservatives could consider cutting tobacco duty, although it would not be an immediate priority. He argued that high taxes fuel illicit cigarette sales and that lowering duty could increase Treasury revenue by reducing tax evasion. Rankin claimed illegal cigarettes account for between a third and half of sales, costing the Treasury £1.7–£4.7 billion. He also criticised “sin taxes” as illiberal and ineffective. Separately, Rishi Sunak’s proposed ban on tobacco purchases by people born after January 1, 2009, was enacted under Labour in April, with restrictions due to begin next year.

A cigarette does not become a public health success because the tax stamp is in order. Legal sales can still mean continued exposure to smoke, disease and premature death, even while governments collect revenue from the product causing the harm. That is the uncomfortable contradiction behind tobacco control built too heavily around compliance. The goal should not be smoke that is properly taxed; it should be fewer people inhaling smoke at all.

The Fifth Circuit ruled that the FDA unlawfully imposed a comparative efficacy standard on flavored vaping products without the notice-and-comment process required by the Administrative Procedure Act. The standard required manufacturers to demonstrate greater benefits for adult smokers than tobacco-flavored products, contributing to widespread marketing denials. The text argues that these barriers restrict potentially lower-risk alternatives for smokers and increase healthcare costs. It also distinguishes lack of FDA authorization from proof that a product is dangerous, noting that authorization does not establish safety. The ruling calls for lawful, transparent regulation that protects young people, allows businesses fair participation, and preserves adult access to potentially beneficial alternatives to cigarettes.

Estonia’s Ministry of Justice has proposed allowing all prisoners to use nicotine pouches and bring them to visitations, matching permissions granted to Swedish inmates at Tartu Prison. The change would avoid difficult searches and unnecessary confiscation, storage, and return procedures.

The draft also introduces risk-based nighttime supervision. Hourly checks would remain mandatory for prisoners under locked-cell regimes, in disciplinary confinement, or identified as suicide risks. Other prisoners would be checked only when security or safety concerns arise. Staff could still inspect any cell when behavior, sounds, or other circumstances warrant it. The proposal aims to reduce unnecessary workload and disturbances to prisoners’ rest and privacy.